Search research articles
Contact Us
Filters
Showing results (1-10 of 12) with videos related to
Page
of 2
Sort By:
Clinical Chemistry
|
September 1, 2022
Commentary on Questionable High Free T4 Concentrations: When Confirming against an Alternative Method Is Not Enough
Andrew R Crawford
Current Atherosclerosis Reports
|
March 8, 2018
Cardiometabolic Effects of Anti-obesity Pharmacotherapy
Andrew R Crawford, Naji Alamuddin, Anastassia Amaro
Rhode Island Medical Journal (2013)
|
March 4, 2020
MRSA Prevalence in Preoperative S. aureus Nasal Culture Isolates is Significantly Different From a Traditional Hospital-wide Antibiogram
Andrew R Crawford, Nancy Vallande, John R Lonks
The Journal of Applied Laboratory Medicine
|
July 29, 2025
Abnormal Thyroid Function Test in a Patient Taking Carbamazepine
Mirjana Barjaktarovic, K Aaron Geno, Andrew R Crawford
JAMA Otolaryngology-- Head & Neck Surgery
|
April 6, 2018
Thyroidosis Mistaken for Thyroid Cancer
Andrew R Crawford, Maria Martinez-Lage, Caroline S Kim
Rare Tumors
|
July 27, 2013
Recurrence of paraneoplastic membranous glomerulonephritis following chemoradiation in a man with non-small-cell lung carcinoma
Andrew R Crawford, Lance Dworkin, Kara Leonard, et al.
Bioorganic & Medicinal Chemistry Letters
|
July 31, 2009
Design and synthesis of (2R,3S)-iodoreboxetine analogues for SPECT imaging of the noradrenaline transporter
Nicola K Jobson, Andrew R Crawford, Deborah Dewar, et al.
Bioorganic & Medicinal Chemistry Letters
|
September 3, 2008
New iodoreboxetine analogues for SPECT imaging of the noradrenaline transporter
Nicola K Jobson, Andrew R Crawford, Deborah Dewar, et al.
Organic & Biomolecular Chemistry
|
June 20, 2008
Stereoselective synthesis of (2S,3R)- and (2R,3S)-iodoreboxetine; potential SPECT imaging agents for the noradrenaline transporter
Nicola K Jobson, Rosemary Spike, Andrew R Crawford, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
February 24, 2010
Negative feedback control of HIF-1 through REDD1-regulated ROS suppresses tumorigenesis
Peter Horak, Andrew R Crawford, Douangsone D Vadysirisack, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 12) with videos related to
Sort By:
Page
of 2
Clinical Chemistry
|
September 1, 2022
Commentary on Questionable High Free T4 Concentrations: When Confirming against an Alternative Method Is Not Enough
Andrew R Crawford
Current Atherosclerosis Reports
|
March 8, 2018
Cardiometabolic Effects of Anti-obesity Pharmacotherapy
Andrew R Crawford, Naji Alamuddin, Anastassia Amaro
Rhode Island Medical Journal (2013)
|
March 4, 2020
MRSA Prevalence in Preoperative S. aureus Nasal Culture Isolates is Significantly Different From a Traditional Hospital-wide Antibiogram
Andrew R Crawford, Nancy Vallande, John R Lonks
The Journal of Applied Laboratory Medicine
|
July 29, 2025
Abnormal Thyroid Function Test in a Patient Taking Carbamazepine
Mirjana Barjaktarovic, K Aaron Geno, Andrew R Crawford
JAMA Otolaryngology-- Head & Neck Surgery
|
April 6, 2018
Thyroidosis Mistaken for Thyroid Cancer
Andrew R Crawford, Maria Martinez-Lage, Caroline S Kim
Rare Tumors
|
July 27, 2013
Recurrence of paraneoplastic membranous glomerulonephritis following chemoradiation in a man with non-small-cell lung carcinoma
Andrew R Crawford, Lance Dworkin, Kara Leonard, et al.
Bioorganic & Medicinal Chemistry Letters
|
July 31, 2009
Design and synthesis of (2R,3S)-iodoreboxetine analogues for SPECT imaging of the noradrenaline transporter
Nicola K Jobson, Andrew R Crawford, Deborah Dewar, et al.
Bioorganic & Medicinal Chemistry Letters
|
September 3, 2008
New iodoreboxetine analogues for SPECT imaging of the noradrenaline transporter
Nicola K Jobson, Andrew R Crawford, Deborah Dewar, et al.
Organic & Biomolecular Chemistry
|
June 20, 2008
Stereoselective synthesis of (2S,3R)- and (2R,3S)-iodoreboxetine; potential SPECT imaging agents for the noradrenaline transporter
Nicola K Jobson, Rosemary Spike, Andrew R Crawford, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
February 24, 2010
Negative feedback control of HIF-1 through REDD1-regulated ROS suppresses tumorigenesis
Peter Horak, Andrew R Crawford, Douangsone D Vadysirisack, et al.
Page
of 2